Pharmadax
FDA Approved Drugs

Pharmadax

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued RX
  • Total Records 17
  • Latest Approval Date Nov 18, 2022
  • Data Source FDA
  • First Approval Date May 25, 2012
All
17
View
Discontinued
13
View
RX
4
View
Company Overview

Company

Pharmadax

Country

Taiwan

Website

Visit Website

Email

mail@pharmadax.com

Social Profiles

LinkedIn
Company Snapshot

Pharmadax

5F-1, No.236, Liancheng Rd, ZhongheDist, New Taipei City 235

Taiwan

www.pharmadax.com.cn/English/Enlish.html mail@pharmadax.com View on Map
FDA Approved Drug Records ( 17 records )
2020
10 Aug
Discontinued Application: 212106

Drug Name

ENTECAVIR

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2020-08-10

212106 / 1

Active Ingredient

ENTECAVIR

Application Number

212106

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2020-08-10

Regulatory Status

Discontinued

2020
10 Aug
Discontinued Application: 212106

Drug Name

ENTECAVIR

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2020-08-10

212106 / 2

Active Ingredient

ENTECAVIR

Application Number

212106

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2020-08-10

Regulatory Status

Discontinued

2012
25 May
Discontinued Application: 201464

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2012-05-25

201464 / 1

Active Ingredient

LEVETIRACETAM

Application Number

201464

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2012-05-25

Regulatory Status

Discontinued

2012
25 May
Discontinued Application: 201464

Drug Name

LEVETIRACETAM

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2012-05-25

201464 / 2

Active Ingredient

LEVETIRACETAM

Application Number

201464

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2012-05-25

Regulatory Status

Discontinued

2020
31 Mar
RX Application: 203028

Drug Name

METOPROLOL SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 25MG TARTRATE

Approval Date

2020-03-31

203028 / 1

Active Ingredient

METOPROLOL SUCCINATE

Application Number

203028

Product Number

1

Dosage Form

-

Strength

EQ 25MG TARTRATE

Approval Date

2020-03-31

Regulatory Status

RX

2020
31 Mar
RX Application: 203028

Drug Name

METOPROLOL SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 50MG TARTRATE

Approval Date

2020-03-31

203028 / 2

Active Ingredient

METOPROLOL SUCCINATE

Application Number

203028

Product Number

2

Dosage Form

-

Strength

EQ 50MG TARTRATE

Approval Date

2020-03-31

Regulatory Status

RX

2020
30 Mar
RX Application: 203699

Drug Name

METOPROLOL SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 100MG TARTRATE

Approval Date

2020-03-30

203699 / 1

Active Ingredient

METOPROLOL SUCCINATE

Application Number

203699

Product Number

1

Dosage Form

-

Strength

EQ 100MG TARTRATE

Approval Date

2020-03-30

Regulatory Status

RX

2020
30 Mar
RX Application: 203699

Drug Name

METOPROLOL SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 200MG TARTRATE

Approval Date

2020-03-30

203699 / 2

Active Ingredient

METOPROLOL SUCCINATE

Application Number

203699

Product Number

2

Dosage Form

-

Strength

EQ 200MG TARTRATE

Approval Date

2020-03-30

Regulatory Status

RX

2022
18 Nov
Discontinued Application: 216019

Drug Name

NIFEDIPINE

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2022-11-18

216019 / 1

Active Ingredient

NIFEDIPINE

Application Number

216019

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2022-11-18

Regulatory Status

Discontinued

2022
18 Nov
Discontinued Application: 216019

Drug Name

NIFEDIPINE

Product Number

2

Dosage Form

-

Strength

60MG

Approval Date

2022-11-18

216019 / 2

Active Ingredient

NIFEDIPINE

Application Number

216019

Product Number

2

Dosage Form

-

Strength

60MG

Approval Date

2022-11-18

Regulatory Status

Discontinued

2017
09 May
Discontinued Application: 206260

Drug Name

QUETIAPINE FUMARATE

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2017-05-09

206260 / 1

Active Ingredient

QUETIAPINE FUMARATE

Application Number

206260

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2017-05-09

Regulatory Status

Discontinued

2017
09 May
Discontinued Application: 206260

Drug Name

QUETIAPINE FUMARATE

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2017-05-09

206260 / 2

Active Ingredient

QUETIAPINE FUMARATE

Application Number

206260

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2017-05-09

Regulatory Status

Discontinued

2017
09 May
Discontinued Application: 206260

Drug Name

QUETIAPINE FUMARATE

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2017-05-09

206260 / 3

Active Ingredient

QUETIAPINE FUMARATE

Application Number

206260

Product Number

3

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2017-05-09

Regulatory Status

Discontinued

2017
09 May
Discontinued Application: 206260

Drug Name

QUETIAPINE FUMARATE

Product Number

4

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2017-05-09

206260 / 4

Active Ingredient

QUETIAPINE FUMARATE

Application Number

206260

Product Number

4

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2017-05-09

Regulatory Status

Discontinued

2017
09 May
Discontinued Application: 206260

Drug Name

QUETIAPINE FUMARATE

Product Number

5

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2017-05-09

206260 / 5

Active Ingredient

QUETIAPINE FUMARATE

Application Number

206260

Product Number

5

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2017-05-09

Regulatory Status

Discontinued

2022
04 Jan
Discontinued Application: 214423

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2022-01-04

214423 / 1

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

214423

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2022-01-04

Regulatory Status

Discontinued

2022
04 Jan
Discontinued Application: 214423

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2022-01-04

214423 / 2

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

214423

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2022-01-04

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    4 View
  • FDA Approved Drugs Database
    17 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
17 total
  • Discontinued
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ENTECAVIR

Application Number

212106

Product Number

1

Active Ingredient

ENTECAVIR

Dosage Form

-

Strength

0.5MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit